Default view
About Us Staff Heinzlmann Andrea

Heinzlmann Andrea


Dr. Heinzlmann Andrea

Department of Anatomy and Histology
Position: assistant professor
+361 478 4100 / 8466
Building E, 1st floor 102.

Office hours: during the semester, every Tuesday: 8:15-9:15

Dr. Andrea Heinzlmann was born in Bajna and after her high school studies she was admitted to the Faculty of General Medicine of Semmelweis University in 1995. In 1998 she joined to the research team of Prof. Dr. Katalin Köves at the Department of Human Morphology and Developmental Biology. In 2004 she started to work as a professor’s assistant at the Department of Human Morphology and Developmental Biology. In 2011, she defended her Ph.D. thesis summa cum laude. In 2014 she was selected as one of the TOP25 emerging talents in the future of medicine under 40 years of age based on her publication activity. Since 2017, she has been working at the Department of Anatomy and Histology, University of Veterinary Medicine. In 2019 she completed the requirements of the University Habilitation procedure. In 2023 she was awarded the Pro Universitate Gold Medal by the Senate of the University of Veterinary Medicine in recognition of her outstanding teaching activities.


Main research field: 

Investigation of the  inhibitory effect of pituitary adenylate cyclase activating polypeptide (PACAP) on ovulation in female rats.

Immunohistochemistry of secretin in the central nervous system.

Effects of progesterone on the undesirable effects of chronic estrogen treatment on the function of hormone-producing cells in the anterior lobe of the pituitary gland and on the distribution of S-100 protein-producing follicular cells in male and female Sprague-Dawley rats.

Pathophysiology of valproic acid and bisphenol treatments in rat models.


List of publications (Top 10): 



Köves K, Szabó E, Kántor O, Heinzlmann A, Szabó F, Csáki Á. Current State of Understanding of the Role of PACAP in the Hypothalamo-Hypophyseal Gonadotropin Functions of Mammals. Front Endocrinol (Lausanne). 2020 Mar 6;11:88. doi: 10.3389/fendo.2020.00088. eCollection 2020.PMID: 32210912

Heinzlmann A, Oláh M, Köves K.: Intranasal application of neuroactive agents (PACAP and β-cyclodextrin) before the „critical period of proestrous stage” can block the ovulation. Biologia Futura,

 Tóth ZE, Heinzlmann A, Hashimoto H, Köves K. Distribution of Secretin Receptors in the Rat Central Nervous System an in situ Hybridization Study. Journal of Molecular Neurosci. 2012, J Mol Neurosci. doi: 10.1007/s12031-012-9895-1., 2012 Oct 11.

Heinzlmann A, Kiss G, Tóth ZE, Dochnal R, Pál Á, Sipos I, Manczinger M, Szabó G, Hashimoto H, Köves K. Intranasal application of secretin, similarly to intracerebroventricular administration, influences the motor behavior of mice probably through specific receptors. J Mol Neurosci. 2012 Nov;48(3):558-64.

Heinzlmann A, Tóth ZE, Köves K. Secretin mRNA in the Subdivisions of Primary Sensory Neurons in the Trigeminal Ganglion of Rats. Journal of Molecular Neurosci, 2011, 43(1):101-108

Heinzlmann A, Koves K, Kovacs M, Csernus V. Sexual dimorphism in the effect of concomitant progesterone administration on changes caused by long-term estrogen treatment in pituitary hormone immunoreactivities of rats. Med Sci Monit. 2011, 25;17(3):BR62-73.

Heinzlmann A, Köves K, Nagy GM. Effect of concomitant progesterone administration or the effect of removal of estrogen on changes caused by long-term estrogen treatment in pituitary VIP immunoreactivities. Endocrine, 2010, 37(3):396-402

Heinzlmann A, Köves K: The characteristic change in the distribution of S-100 immunoreactive folliculostellate cells in rat anterior pituitary upon long-term estrogen treatment is prevented by concomitant progesterone treatment. Endocrine, 2008, 33(3):342-348

Heinzlmann A, Kirilly E, Meltzer K, Szabó E, Baba A, Hashimoto H, Köves K. PACAP is transiently expressed in anterior pituitary gland of rats. In situ hybridization and cell immunoblot assay studies.  Peptides, 2008, 29(4):571-577

Heinzlmann A, Kovács M, Köves K. 2007: Undesired changes caused by long term estrogen treatment in the immunoreactivity of LH, FSH, PRL, ACTH and S-100 (present in folliculostellate cells) is modified by concommitant progesterone administration. Acta Biologica Szegediensis 51, Suppl. 1: 14.